• Home
  • Loss of p16 expression is a sensitive marker of CDKN2A homozygous deletion in malignant meningiomas.

Loss of p16 expression is a sensitive marker of CDKN2A homozygous deletion in malignant meningiomas.

Author List
Tang V, Lu R, Mirchia K, Van Ziffle J, Devine P, Lee J, Phillips JJ, Perry A, Raleigh DR, Lucas CG, Solomon DA
Publication
Acta neuropathologica
Publication ID (Profile URL)
https://researcherprofiles.org/profile/365329653
Publication Year
2023
PubMed ID
36723772
Publication Title
Tang V, Lu R, Mirchia K, Van Ziffle J, Devine P, Lee J, Phillips JJ, Perry A, Raleigh DR, Lucas CG, Solomon DA. Loss of p16 expression is a sensitive marker of CDKN2A homozygous deletion in malignant meningiomas. Acta Neuropathol. 2023 04; 145(4):497-500.